Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04445233 · ClinicalTrials.gov registry record
COVID-19 Household Transmission Study
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 315
- Enrollment target
NCT04445233 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 315 participants.
The verdict
NCT04445233 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 315 participants
- Enrollment target
Study Summary
This study will test and follow persons quarantined at home after testing positive for SARS-CoV-2 (COV) aged 18 years and older and their household members aged 1 year and older. The purpose of this research study is to understand how often COVID-19 (Coronavirus Disease 2019) spreads in the household when someone who tests positive for the virus self-isolates at home. The purpose of the extension part of the study is to help us understand long-term immunity to COVID-19. We are interested in how our immune system might still protect us from COVID-19 even after antibody levels decrease or are no longer detected. We are also interested in how immunity to COVID-19 is different in kids vs. adults.
Interventions
- DEVICE COVID-19 IgM-IgG Rapid Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2020-04-29 |
| Est. Completion | 2021-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04445233
The ClinicalTrials.gov registry entry for NCT04445233 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 315 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which COVID-19 IgM-IgG Rapid Test is the first listed.
NCT04445233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04445233 about?
NCT04445233 is a clinical study titled "COVID-19 Household Transmission Study". This study will test and follow persons quarantined at home after testing positive for SARS-CoV-2 (COV) aged 18 years and older and their household members aged 1 year and older. The purpose of this research study is to understand how often COVID-19 (Coronavirus Disease 2019) spreads in the househo...
What is the current status of trial NCT04445233?
This trial is currently completed. The enrollment target is 315 participants. The study started on 2020-04-29. Estimated completion is 2021-09-01.
What interventions are being tested in trial NCT04445233?
The interventions under investigation include: COVID-19 IgM-IgG Rapid Test (DEVICE).
Who is sponsoring clinical trial NCT04445233?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.